Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 1.000 | |
3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.560 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.557 | |
2ofv | 242 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.548 | |
2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.546 | |
4at4 | T6E | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.544 | |
4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.536 | |
2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.534 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.527 | |
2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.514 | |
3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.512 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.510 | |
4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.508 | |
1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.507 | |
3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.506 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.506 | |
3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.505 | |
1fds | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.502 | |
2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.501 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.500 | |
1xu7 | CPS | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.498 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.498 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.495 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.494 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.494 | |
3up0 | D7S | aceDAF-12 | / | 0.494 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.493 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.491 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.491 | |
2osc | MUH | Angiopoietin-1 receptor | 2.7.10.1 | 0.489 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.488 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.487 | |
5c6c | CMP | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.487 | |
3qak | UKA | Adenosine receptor A2a | / | 0.487 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.485 | |
2qu5 | 276 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.485 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.485 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.484 | |
4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.484 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.483 | |
1buc | FAD | Acyl-CoA dehydrogenase, short-chain specific | 1.3.8.1 | 0.482 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.482 | |
2i0v | 6C3 | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.482 | |
2jdd | ACO | Probable acetyltransferase | / | 0.482 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.481 | |
2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.481 | |
3byz | H11 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.479 | |
3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.479 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
5g53 | NEC | Adenosine receptor A2a | / | 0.479 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.479 | |
1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.478 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.478 | |
2w5b | AGS | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.478 | |
4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.478 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.477 | |
2imk | GTX | AGAP009194-PA | / | 0.477 | |
2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.477 | |
2rbe | ZMG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.477 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.477 | |
3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.477 | |
4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.477 | |
3bxx | QUE | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.476 | |
3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.476 | |
3p6n | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.476 | |
2i5n | UQ1 | Reaction center protein L chain | / | 0.475 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.475 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.474 | |
3l6j | Z90 | Alr2278 protein | / | 0.474 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.473 | |
1eii | RTL | Retinol-binding protein 2 | / | 0.473 | |
1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.473 | |
3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.473 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.473 | |
4l5b | 1UX | Deoxycytidine kinase | 2.7.1.74 | 0.473 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.472 | |
2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.472 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.472 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.472 | |
1dgf | NDP | Catalase | 1.11.1.6 | 0.471 | |
2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.471 | |
2rqf | JH3 | Hemolymph juvenile hormone binding protein | / | 0.471 | |
2zev | B71 | Geranylgeranyl pyrophosphate synthase | / | 0.471 | |
4iae | 1DX | Alr2278 protein | / | 0.471 | |
4iah | 1DX | Alr2278 protein | / | 0.471 | |
1upw | 444 | Oxysterols receptor LXR-beta | / | 0.470 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.470 | |
4jvl | EST | Estrogen sulfotransferase | 2.8.2.4 | 0.470 | |
1fp1 | HCC | Isoliquiritigenin 2'-O-methyltransferase | / | 0.469 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.469 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.469 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.469 | |
3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.469 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.469 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.468 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
3qri | 919 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.468 | |
1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.467 | |
1qjf | ACS | Isopenicillin N synthase | 1.21.3.1 | 0.467 | |
4a81 | DXC | Major pollen allergen Bet v 1-A | / | 0.467 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.466 | |
1cqp | 803 | Integrin alpha-L | / | 0.466 | |
2ivn | ANP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.466 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.466 | |
3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.466 | |
3gkj | HC3 | Niemann-Pick C1 protein | / | 0.466 | |
3p3z | P3Z | Putative cytochrome P450 | / | 0.466 | |
3qcz | ANP | Dihydrofolate synthase/folylpolyglutamate synthase | / | 0.466 | |
5hwr | COA | Hydroxymethylglutaryl-CoA synthase | / | 0.466 | |
2x7h | PFN | Prostaglandin reductase 3 | 1 | 0.465 | |
3gki | CLR | Niemann-Pick C1 protein | / | 0.465 | |
4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.465 | |
5bt4 | 2LO | Bromodomain-containing protein 4 | / | 0.465 | |
1daj | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.464 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.464 | |
3jyn | NDP | Quinone oxidoreductase | / | 0.464 | |
3owu | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.464 | |
3tda | PN0 | Cytochrome P450 2D6 | / | 0.464 | |
3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.464 | |
1cbq | RE9 | Cellular retinoic acid-binding protein 2 | / | 0.463 | |
1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.463 | |
1uae | UD1 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.463 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
3a78 | 3EV | Vitamin D3 receptor | / | 0.463 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.463 | |
5cc9 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.463 | |
2ntj | P1H | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.462 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.462 | |
3a1l | 2CC | Cytochrome P450 | / | 0.462 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.462 | |
3h4v | DVP | Pteridine reductase 1 | 1.5.1.33 | 0.462 | |
3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.462 | |
3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.462 | |
3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.462 | |
3w0g | W07 | Vitamin D3 receptor | / | 0.462 | |
4a83 | DXC | Major pollen allergen Bet v 1-A | / | 0.462 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.462 | |
4hvs | 647 | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.462 | |
1oyn | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.461 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.461 | |
3ar6 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.461 | |
4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.461 | |
4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.461 | |
4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.461 | |
4ubt | COA | Steroid 3-ketoacyl-CoA thiolase | / | 0.461 | |
4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.461 | |
1dgh | NDP | Catalase | 1.11.1.6 | 0.460 | |
1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.460 | |
1rrm | APR | Lactaldehyde reductase | 1.1.1.77 | 0.460 | |
2aaz | CB3 | Thymidylate synthase | 2.1.1.45 | 0.460 | |
3ol5 | SAW | Camphor 5-monooxygenase | 1.14.15.1 | 0.460 | |
3p2o | NAD | Bifunctional protein FolD | / | 0.460 | |
3p6p | A6B | Camphor 5-monooxygenase | 1.14.15.1 | 0.460 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.460 | |
4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.460 | |
4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.460 | |
4jqh | 1MF | Alr2278 protein | / | 0.460 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.460 | |
4y8v | ADP | Acyl-CoA synthetase (NDP forming) | / | 0.460 | |
3uza | T4G | Adenosine receptor A2a | / | 0.460 | |
1cbs | REA | Cellular retinoic acid-binding protein 2 | / | 0.459 | |
1h42 | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.459 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.459 | |
1osv | CHC | Bile acid receptor | / | 0.459 | |
1xdd | AAY | Integrin alpha-L | / | 0.459 | |
1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.459 | |
3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
3ghv | GHC | Dihydrofolate reductase | 1.5.1.3 | 0.459 | |
3pyz | ANP | Dihydrofolate synthase/folylpolyglutamate synthase | / | 0.459 | |
1mc5 | AHE | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.458 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.458 | |
1xu9 | CPS | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.458 | |
2r6j | NDP | Eugenol synthase 1 | 1.1.1.318 | 0.458 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.458 | |
3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.458 | |
3oey | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.458 | |
3rfm | CFF | Adenosine receptor A2a | / | 0.458 | |
1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.457 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
2aib | ERG | Beta-elicitin cinnamomin | / | 0.457 | |
2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.457 | |
2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.457 | |
2hve | ADP | Nucleoside diphosphate kinase A | 2.7.4.6 | 0.457 | |
3c3x | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.457 | |
3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.457 | |
3k4n | FAD | Pyranose 2-oxidase | / | 0.457 | |
3rj0 | BLD | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.457 | |
3uax | NOS | Purine nucleoside phosphorylase DeoD-type | / | 0.457 | |
3w0h | W12 | Vitamin D3 receptor | / | 0.457 | |
4bj9 | UHB | Tankyrase-2 | 2.4.2.30 | 0.457 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
1e7a | PFL | Serum albumin | / | 0.456 | |
1gqy | ACP | UDP-N-acetylmuramate--L-alanine ligase | 6.3.2.8 | 0.456 | |
1q20 | PLO | Sulfotransferase family cytosolic 2B member 1 | 2.8.2.2 | 0.456 | |
1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.456 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
1y2k | 7DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
2oz5 | 7XY | Uncharacterized protein | / | 0.456 | |
2r0p | K2C | Putative FAD-monooxygenase | / | 0.456 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.456 | |
2zu9 | GDP | Mannosyl-3-phosphoglycerate synthase | 2.4.1.217 | 0.456 | |
3e92 | G6A | Mitogen-activated protein kinase 14 | / | 0.456 | |
3g7f | UQ1 | Reaction center protein L chain | / | 0.456 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.456 | |
4dsb | A8S | Abscisic acid receptor PYL3 | / | 0.456 | |
4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.456 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.456 | |
4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.456 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.456 | |
1cbr | REA | Cellular retinoic acid-binding protein 1 | / | 0.455 | |
1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.455 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.455 | |
2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.455 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.455 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.455 | |
3ch6 | 311 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.455 | |
4dsc | A8S | Abscisic acid receptor PYL3 | / | 0.455 | |
1d3p | BT3 | Prothrombin | 3.4.21.5 | 0.454 | |
1k4g | AIQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.454 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.454 | |
1o8c | NDP | Probable acrylyl-CoA reductase AcuI | 1.3.1.84 | 0.454 | |
1p44 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
2jdv | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
2oye | IM8 | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.454 | |
2wuf | KEM | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.454 | |
3ar5 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.454 | |
4dvi | 2IW | Tankyrase-1 | 2.4.2.30 | 0.454 | |
4pd6 | URI | Nucleoside permease | / | 0.454 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.454 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.454 | |
1mrq | STR | Aldo-keto reductase family 1 member C1 | / | 0.453 | |
1ot7 | CHC | Bile acid receptor | / | 0.453 | |
1sd2 | MTH | S-methyl-5'-thioadenosine phosphorylase | / | 0.453 | |
1t4c | COA | Formyl-CoA:oxalate CoA-transferase | / | 0.453 | |
2bbq | PFG | Thymidylate synthase | / | 0.453 | |
2jdc | CAO | Probable acetyltransferase | / | 0.453 | |
2pnu | ENM | Androgen receptor | / | 0.453 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.453 | |
3eig | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.453 | |
3thr | C2F | Glycine N-methyltransferase | 2.1.1.20 | 0.453 | |
3uk6 | ADP | RuvB-like 2 | 3.6.4.12 | 0.453 | |
3up3 | XCA | aceDAF-12 | / | 0.453 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.453 | |
4a4x | JUP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.453 | |
4fdn | FAD | Decaprenylphosphoryl-beta-D-ribose oxidase | / | 0.453 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.453 | |
5ab6 | CAA | Nonspecific lipid-transfer protein, putative | / | 0.453 | |
1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
1tdu | CB3 | Thymidylate synthase | / | 0.452 | |
1v7a | FRC | Adenosine deaminase | 3.5.4.4 | 0.452 | |
2d29 | FAD | Acyl-CoA dehydrogenase | / | 0.452 | |
2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.452 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.452 | |
3h0b | B35 | Beta-secretase 1 | 3.4.23.46 | 0.452 | |
3icz | PB6 | Farnesyl pyrophosphate synthase | / | 0.452 | |
3p6m | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.452 | |
4a84 | DXC | Major pollen allergen Bet v 1-A | / | 0.452 | |
4cvm | ANP | UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase | / | 0.452 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.452 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.452 | |
5doz | NDP | JamJ | / | 0.452 | |
1jom | FFO | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
1uuo | BRF | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.451 | |
1w29 | TS0 | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.451 | |
1xuo | LA1 | Integrin alpha-L | / | 0.451 | |
1ygj | RMC | Pyridoxal kinase | 2.7.1.35 | 0.451 | |
1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.451 | |
2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.451 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.451 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.451 | |
3cho | 4BG | Leukotriene A-4 hydrolase | 3.3.2.6 | 0.451 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.451 | |
3gts | D3M | DdmC | / | 0.451 | |
3mje | NDP | AmphB | / | 0.451 | |
3nx4 | NAP | Putative oxidoreductase | / | 0.451 | |
4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.451 | |
4at5 | MUJ | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.451 | |
4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
4uug | PXG | Branched-chain amino acid aminotransferase, putative | / | 0.451 | |
5cp8 | TCU | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
5iub | CLR | Adenosine receptor A2a | / | 0.451 | |
1d3d | BZT | Prothrombin | 3.4.21.5 | 0.450 | |
1w7k | ADP | Dihydrofolate synthase/folylpolyglutamate synthase | 6.3.2.12 | 0.450 | |
2agv | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.450 | |
2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.450 | |
2vd0 | D27 | Hematopoietic prostaglandin D synthase | / | 0.450 | |
3bx5 | 304 | Mitogen-activated protein kinase 14 | / | 0.450 | |
3oew | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.450 | |
3p9t | TCL | Repressor | / | 0.450 | |
3vwe | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.450 | |
3w5r | LOA | Vitamin D3 receptor | / | 0.450 | |
4hcy | 0YN | Transketolase | / | 0.450 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.450 | |
4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.450 | |
4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.450 | |
4u9z | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.450 | |
7cat | NDP | Catalase | 1.11.1.6 | 0.450 | |
1jut | LYD | Thymidylate synthase | / | 0.449 | |
2ed3 | SAH | Diphthine synthase | / | 0.449 | |
2h44 | 7CA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.449 | |
2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.449 | |
2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.449 | |
3ngu | ADP | Nucleoside diphosphate kinase | / | 0.449 | |
3ozc | 4CT | S-methyl-5'-thioadenosine phosphorylase | / | 0.449 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.449 | |
4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.449 | |
4rh1 | 0TT | Spore photoproduct lyase | / | 0.449 | |
4x5j | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
5dc5 | B3N | Histone deacetylase 8 | 3.5.1.98 | 0.449 | |
1d6w | 00R | Prothrombin | 3.4.21.5 | 0.448 | |
1fdt | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.448 | |
1n9m | BTN | Streptavidin | / | 0.448 | |
1uyd | PU8 | Heat shock protein HSP 90-alpha | / | 0.448 | |
1x8l | OXR | Retinol dehydratase | / | 0.448 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.448 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.448 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
3bsy | ACO | UDP-N-acetylbacillosamine N-acetyltransferase | 2.3.1.203 | 0.448 | |
3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.448 | |
3nx2 | FER | Ferulic acid decarboxylase | / | 0.448 | |
4a30 | QMI | Glycylpeptide N-tetradecanoyltransferase | / | 0.448 | |
4c1f | X8Z | Metallo-beta-lactamase type 2 | / | 0.448 | |
4eqc | XR1 | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.448 | |
4jtr | IZP | Aldo-keto reductase family 1 member C2 | / | 0.448 | |
4ozt | P1A | Ecdysone receptor, putative | / | 0.448 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.448 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.448 | |
1cf3 | FAD | Glucose oxidase | 1.1.3.4 | 0.447 | |
1u8f | NAD | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.12 | 0.447 | |
1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.447 | |
2j9l | ATP | H(+)/Cl(-) exchange transporter 5 | / | 0.447 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.447 | |
2vcw | ZZA | Hematopoietic prostaglandin D synthase | / | 0.447 | |
2xkc | 4VQ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.447 | |
2xkf | BX1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.447 | |
3ar7 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.447 | |
3cbs | R12 | Cellular retinoic acid-binding protein 2 | / | 0.447 | |
3g49 | 3G4 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.447 | |
3inx | JZC | Heat shock protein HSP 90-alpha | / | 0.447 | |
3kxo | KXO | Hematopoietic prostaglandin D synthase | / | 0.447 | |
3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.447 | |
3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.447 | |
3vwd | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.447 | |
3zec | ANP | Adenosine monophosphate-protein transferase SoFic | 2.7.7.n1 | 0.447 | |
4at3 | LTI | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.447 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
4bfw | ZVW | Pantothenate kinase | 2.7.1.33 | 0.447 | |
4dk7 | 0KS | Oxysterols receptor LXR-beta | / | 0.447 | |
4n3l | 2FN | Prothrombin | 3.4.21.5 | 0.447 | |
4qx5 | CMP | cGMP-dependent protein kinase 1 | 2.7.11.12 | 0.447 | |
5d7q | 4I5 | NAD-dependent protein deacetylase sirtuin-2 | 3.5.1 | 0.447 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.447 | |
1dgb | NDP | Catalase | 1.11.1.6 | 0.446 | |
1rf9 | DBR | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
1txt | CAA | HMG-CoA synthase | / | 0.446 | |
1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
2b01 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.446 | |
2bel | CBO | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
2e98 | B29 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.446 | |
2ntv | P1H | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.446 | |
2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.446 | |
2yp0 | OVE | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.446 | |
4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.446 | |
4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.446 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.446 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
4gue | QCT | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.446 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.446 | |
4kln | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.446 | |
1swd | BTN | Streptavidin | / | 0.445 | |
1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.445 | |
2bns | MST | Reaction center protein L chain | / | 0.445 | |
2hps | CTZ | Ca2+-triggered coelenterazine-binding protein 1 | / | 0.445 | |
2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.445 | |
2nnq | T4B | Fatty acid-binding protein, adipocyte | / | 0.445 | |
2p15 | EZT | Estrogen receptor | / | 0.445 | |
3dh7 | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.445 | |
3nu0 | 3TU | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
3u8h | BHP | Phospholipase A2, membrane associated | / | 0.445 | |
3v0o | 4GW | Histo-blood group ABO system transferase | / | 0.445 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
4af7 | FAD | Ferredoxin--NADP reductase, leaf isozyme, chloroplastic | 1.18.1.2 | 0.445 | |
4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.445 | |
4ia3 | BIV | Vitamin D3 receptor A | / | 0.445 | |
4qij | 1HA | 1,4-dihydroxy-2-naphthoyl-CoA synthase | / | 0.445 | |
5hbs | RTL | Retinol-binding protein 1 | / | 0.445 | |
1dis | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
1hvy | D16 | Thymidylate synthase | 2.1.1.45 | 0.444 | |
1nbh | SAM | Glycine N-methyltransferase | 2.1.1.20 | 0.444 | |
1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.444 | |
2dvl | FAD | Acyl-CoA dehydrogenase | / | 0.444 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
2z7h | GG3 | Geranylgeranyl pyrophosphate synthase | / | 0.444 | |
3dei | RXB | Caspase-3 | 3.4.22.56 | 0.444 | |
3ey4 | 352 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.444 | |
3kp4 | MII | Transcriptional regulator TcaR | / | 0.444 | |
3ndv | AIC | Beta-peptidyl aminopeptidase BapA | / | 0.444 | |
3oq1 | 3OQ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
3pqb | VGP | Putative oxidoreductase | / | 0.444 | |
3zia | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.444 | |
4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.444 | |
4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.444 | |
4fhi | 0S4 | Vitamin D3 receptor A | / | 0.444 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
4isk | 1JY | Thymidylate synthase | / | 0.444 | |
4ryv | ZEA | Protein LlR18A | / | 0.444 | |
4ttj | FMC | Purine nucleoside phosphorylase DeoD-type | / | 0.444 | |
1drf | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
1re9 | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
2bjs | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
2dhf | DZF | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
2e99 | B08 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.443 | |
2fjd | SFD | Adenylylsulfate reductase, subunit A (AprA) | / | 0.443 | |
2ilt | NN1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.443 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.443 | |
2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.443 | |
2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.443 | |
2z3u | CRR | Cytochrome P450 | / | 0.443 | |
3dfr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3e7i | B2 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.443 | |
3iel | U5P | Ribonuclease TTHA0252 | 3.1 | 0.443 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.443 | |
3slk | NDP | Polyketide synthase extender module 2 | / | 0.443 | |
4cax | 646 | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.443 | |
4ez8 | DHF | Thymidylate synthase | 2.1.1.45 | 0.443 | |
4kw5 | 1W6 | Decaprenylphosphoryl-beta-D-ribose oxidase | / | 0.443 | |
4kwi | 1TJ | Reductase homolog | / | 0.443 | |
4o9c | COA | Acetyl-CoA acetyltransferase | 2.3.1.9 | 0.443 | |
4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.443 | |
4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.443 | |
1dna | CB3 | Thymidylate synthase | / | 0.442 | |
1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.442 | |
1jjt | BDS | Beta-lactamase | / | 0.442 | |
1lri | CLR | Beta-elicitin cryptogein | / | 0.442 | |
1ne6 | SP1 | cAMP-dependent protein kinase type I-alpha regulatory subunit | / | 0.442 | |
1oj4 | CDM | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.442 | |
1s7n | COA | Acetyl transferase | / | 0.442 | |
2ejz | SAH | Diphthine synthase | / | 0.442 | |
2ic5 | GNP | Ras-related C3 botulinum toxin substrate 3 | / | 0.442 | |
2o7p | NAP | Riboflavin biosynthesis protein RibD | / | 0.442 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.442 | |
2xf3 | J01 | Uncharacterized protein | / | 0.442 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
3abi | NAD | Uncharacterized protein | / | 0.442 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.442 | |
3eta | 351 | Insulin receptor | 2.7.10.1 | 0.442 | |
3hmv | HBT | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.442 | |
3vi5 | M4M | Hematopoietic prostaglandin D synthase | / | 0.442 | |
3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.442 | |
4ia1 | BIV | Vitamin D3 receptor A | / | 0.442 | |
4j52 | 1J3 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.442 | |
4k4e | K4E | Tankyrase-1 | 2.4.2.30 | 0.442 | |
4n1f | CZH | Obelin | / | 0.442 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.442 | |
4rvg | TYD | D-mycarose 3-C-methyltransferase | / | 0.442 | |
4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.442 | |
5emh | NAP | Iridoid synthase | 1.3.1.99 | 0.442 | |
1dfo | FFO | Serine hydroxymethyltransferase | 2.1.2.1 | 0.441 | |
1juj | LYA | Thymidylate synthase | 2.1.1.45 | 0.441 | |
1kzu | RG1 | Light-harvesting protein B-800/850 alpha chain | / | 0.441 | |
1kzu | RG1 | Light-harvesting protein B-800/850 beta chain | / | 0.441 | |
1mvt | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1p3d | ANP | UDP-N-acetylmuramate--L-alanine ligase | 6.3.2.8 | 0.441 | |
1w7h | 3IP | Mitogen-activated protein kinase 14 | / | 0.441 | |
1z6t | ADP | Apoptotic protease-activating factor 1 | / | 0.441 | |
2bfm | TOP | Pteridine reductase 1 | 1.5.1.33 | 0.441 | |
2igx | A1T | Plasmepsin 2 | / | 0.441 | |
3arp | DEQ | Chitinase A | / | 0.441 | |
3atz | FMN | Prostaglandin F2a synthase | / | 0.441 | |
3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.441 | |
3da2 | 4MD | Carbonic anhydrase 13 | 4.2.1.1 | 0.441 | |
3gwf | NAP | Cyclohexanone monooxygenase | / | 0.441 | |
3h3s | H15 | Collagen type IV alpha-3-binding protein | / | 0.441 | |
3hu2 | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.441 | |
3hz5 | Z64 | Heat shock protein HSP 90-alpha | / | 0.441 | |
3ntg | D72 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.441 | |
4bcr | WY1 | Peroxisome proliferator-activated receptor alpha | / | 0.441 | |
4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
4hx5 | 19V | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
4l4x | NDP | AmphI | / | 0.441 | |
4lm4 | JPZ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
4mv8 | ACP | Biotin carboxylase | 6.3.4.14 | 0.441 | |
5ark | UMP | Ribonuclease 4 | 3.1.27 | 0.441 | |
1dli | UDX | UDP-glucose 6-dehydrogenase | / | 0.440 | |
1kt6 | RTL | Retinol-binding protein 4 | / | 0.440 | |
1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.440 | |
1xkd | NAP | Isocitrate dehydrogenase [NADP] | / | 0.440 | |
2ovv | PFH | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
2r04 | W71 | Genome polyprotein | / | 0.440 | |
2vig | FAD | Short-chain specific acyl-CoA dehydrogenase, mitochondrial | 1.3.8.1 | 0.440 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.440 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
3aos | JH2 | Hemolymph juvenile hormone binding protein | / | 0.440 | |
3bbf | GDP | Nucleoside diphosphate kinase B | 2.7.4.6 | 0.440 | |
3bgx | MEF | Thymidylate synthase | / | 0.440 | |
3dyl | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.440 | |
3of2 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
3qly | 55V | Uncharacterized protein | / | 0.440 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.440 | |
4blc | NDP | Catalase | 1.11.1.6 | 0.440 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.440 | |
4imw | H4B | Nitric oxide synthase, brain | 1.14.13.39 | 0.440 | |
4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.440 | |
4ol0 | GTP | GTP-binding nuclear protein Ran | / | 0.440 | |
4rlh | 0WE | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.440 | |
5fm7 | ADP | RuvB-like helicase | / | 0.440 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.440 | |
4ug2 | NGI | Adenosine receptor A2a | / | 0.440 |